CN105561346B - 一种超声造影剂的制备方法 - Google Patents
一种超声造影剂的制备方法 Download PDFInfo
- Publication number
- CN105561346B CN105561346B CN201511015312.0A CN201511015312A CN105561346B CN 105561346 B CN105561346 B CN 105561346B CN 201511015312 A CN201511015312 A CN 201511015312A CN 105561346 B CN105561346 B CN 105561346B
- Authority
- CN
- China
- Prior art keywords
- chicken blood
- buffered saline
- saline solution
- phosphate buffered
- contrast agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002872 contrast media Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 46
- 241000287828 Gallus gallus Species 0.000 claims abstract description 38
- 239000006228 supernatant Substances 0.000 claims abstract description 33
- 239000013049 sediment Substances 0.000 claims abstract description 32
- 239000000243 solution Substances 0.000 claims abstract description 28
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims abstract description 26
- 239000002953 phosphate buffered saline Substances 0.000 claims abstract description 26
- 239000008280 blood Substances 0.000 claims abstract description 24
- 210000004369 blood Anatomy 0.000 claims abstract description 24
- 235000011187 glycerol Nutrition 0.000 claims abstract description 23
- 239000012267 brine Substances 0.000 claims abstract description 20
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims abstract description 20
- 239000003918 blood extract Substances 0.000 claims abstract description 16
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000005119 centrifugation Methods 0.000 claims abstract description 13
- 102000004882 Lipase Human genes 0.000 claims abstract description 8
- 108090001060 Lipase Proteins 0.000 claims abstract description 8
- 239000004367 Lipase Substances 0.000 claims abstract description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims abstract description 8
- 235000011130 ammonium sulphate Nutrition 0.000 claims abstract description 8
- 235000019421 lipase Nutrition 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 235000010344 sodium nitrate Nutrition 0.000 claims abstract description 7
- 239000004317 sodium nitrate Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims description 24
- 238000007710 freezing Methods 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 239000000155 melt Substances 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 238000003384 imaging method Methods 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000004088 pulmonary circulation Effects 0.000 abstract description 5
- 239000011248 coating agent Substances 0.000 abstract description 4
- 238000000576 coating method Methods 0.000 abstract description 4
- 239000000047 product Substances 0.000 abstract description 4
- 238000004821 distillation Methods 0.000 abstract description 3
- 238000004090 dissolution Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 238000002604 ultrasonography Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000004255 ion exchange chromatography Methods 0.000 description 4
- 238000009938 salting Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- JFDRXEGUWGGADQ-UHFFFAOYSA-N [Na+].[O-][N+]([O-])=O.OCC(O)CO Chemical compound [Na+].[O-][N+]([O-])=O.OCC(O)CO JFDRXEGUWGGADQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000002086 displacement chromatography Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Acoustics & Sound (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015312.0A CN105561346B (zh) | 2015-12-31 | 2015-12-31 | 一种超声造影剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015312.0A CN105561346B (zh) | 2015-12-31 | 2015-12-31 | 一种超声造影剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105561346A CN105561346A (zh) | 2016-05-11 |
CN105561346B true CN105561346B (zh) | 2018-05-18 |
Family
ID=55872336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511015312.0A Expired - Fee Related CN105561346B (zh) | 2015-12-31 | 2015-12-31 | 一种超声造影剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105561346B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004105802A1 (en) * | 2003-05-27 | 2004-12-09 | Philips Intellectual Property & Standards Gmbh | Tracer for medical imaging |
CN1698652A (zh) * | 2005-04-20 | 2005-11-23 | 沈阳斯佳科技发展有限公司 | 从猪血中提取具有刺激细胞呼吸活性作用物质的方法 |
CN101366727A (zh) * | 2008-09-27 | 2009-02-18 | 高翔 | 一种小牛血去蛋白提取物的制备方法及其产品 |
CN101957366A (zh) * | 2009-07-15 | 2011-01-26 | 英科新创(厦门)科技有限公司 | 人红细胞膜抗原包被的微球及其应用 |
CN102466730A (zh) * | 2010-11-19 | 2012-05-23 | 南京神州英诺华医疗科技有限公司 | 一种新的配制血型反定型试剂的方法 |
US20140066761A1 (en) * | 2012-02-22 | 2014-03-06 | Alexander A. Oraevsky | Optoacoustic-Ultrasonic Contrast Agents with Enhanced Efficiency |
-
2015
- 2015-12-31 CN CN201511015312.0A patent/CN105561346B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004105802A1 (en) * | 2003-05-27 | 2004-12-09 | Philips Intellectual Property & Standards Gmbh | Tracer for medical imaging |
CN1698652A (zh) * | 2005-04-20 | 2005-11-23 | 沈阳斯佳科技发展有限公司 | 从猪血中提取具有刺激细胞呼吸活性作用物质的方法 |
CN101366727A (zh) * | 2008-09-27 | 2009-02-18 | 高翔 | 一种小牛血去蛋白提取物的制备方法及其产品 |
CN101957366A (zh) * | 2009-07-15 | 2011-01-26 | 英科新创(厦门)科技有限公司 | 人红细胞膜抗原包被的微球及其应用 |
CN102466730A (zh) * | 2010-11-19 | 2012-05-23 | 南京神州英诺华医疗科技有限公司 | 一种新的配制血型反定型试剂的方法 |
US20140066761A1 (en) * | 2012-02-22 | 2014-03-06 | Alexander A. Oraevsky | Optoacoustic-Ultrasonic Contrast Agents with Enhanced Efficiency |
Non-Patent Citations (4)
Title |
---|
Microbubble contrast agents: a new era in ultrasound;Martin J K Blomley,et al,;《BMJ》;20010519;第322卷;第1222-1225页 * |
Use of Ultrasound Contrast Agents for Gene or Drug Delivery in Cardiovascular Medicine;Raffi Bekeredjian,et al;《Journal of the American College of Cardiology》;20050201;第45卷(第3期);第329-335页 * |
超声造影剂靶向性作用机制的研究进展;景香香 等,;《临床超声医学杂志》;20131230;第5卷(第6期);第359-360页 * |
靶向微泡造影技术的研究进展;刘晓婷 等,;《中华医学超声杂志》;20140901;第11卷(第9期);第706-709页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105561346A (zh) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hirsova et al. | Extracellular vesicles in liver pathobiology: small particles with big impact | |
CN106421880A (zh) | 一种乌贼墨多糖/壳聚糖止血海绵及其制备方法和应用 | |
CN106119329A (zh) | 一种同步多频超声辅助固定化酶酶解制备玉米多肽的方法 | |
CN105561346B (zh) | 一种超声造影剂的制备方法 | |
CN106053172B (zh) | 一种edta抗原修复液 | |
CN105999314B (zh) | 一种超声造影剂及其制备方法 | |
CN106853263A (zh) | 一种人工皮肤及其制备方法 | |
Sperber et al. | The Controlled Sodium Amalgam Reduction of Aldonolactones and their Esters to Aldoses and an Improved Synthesis of D-Arabinose1 | |
CN106434622A (zh) | 一种共固定化酶的制备方法 | |
CN102349582B (zh) | 一种超临界co2体系中用脂肪酶膜制备富含中链脂肪酸的玉米油的方法 | |
Al-Mansour et al. | Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by optison | |
CN107254495A (zh) | 脂肪酶催化酶解稻米油制备甘油二酯的方法 | |
CN105987839B (zh) | 一种edta-柠檬酸抗原修复液 | |
CN103524758A (zh) | 凝胶聚合反应原液制作工艺、智能仿生体模及其制作工艺 | |
CN107115360A (zh) | 一种驴皮加工工艺 | |
Perrot et al. | Simultaneous pulse wave and flow estimation at high-framerate using plane wave and transverse oscillation on carotid phantom | |
CN107034259A (zh) | 一种高热稳定性中华鳖副产物胶原蛋白的制备方法 | |
CN115591036A (zh) | 分解血液中苯丙氨酸的血液灌流器填料的制备方法 | |
CN104739694A (zh) | 一种保湿水及其制备方法 | |
CN102550796A (zh) | 蝗虫蛋白粉的制作工艺 | |
CN108815565A (zh) | 一种具有高吸水倍率止血海绵及其制备方法 | |
CN208440594U (zh) | 甲壳素生产线 | |
CN206177669U (zh) | 一种用于猪肉中沙丁胺醇成分检测的底物液制备装置 | |
JPS6167457A (ja) | 冷凍こんにやくの製造法 | |
CN103410002B (zh) | 一种含有聚乙二醇双硬脂酸酯的羊毛衫处理剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Bin Inventor after: Zhang Shibo Inventor after: Liu Jikuan Inventor before: Chen Rongrong Inventor before: Lei Guoqing |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180420 Address after: 276600 Junan County People's Hospital, 156 Tianqiao Road, Junan, Shandong Applicant after: Li Bin Address before: 213164, Paris Road, Xinbei District, Xinbei District, Jiangsu, Changzhou, 27 Applicant before: CHANGZHOU CHANGYU PRACTICAL GAS CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180518 Termination date: 20181231 |
|
CF01 | Termination of patent right due to non-payment of annual fee |